Jeffrey S Berger

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. ncbi Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004
    Jeffrey S Berger
    Department of Medicine, Division of Cardiology and Hematology, New York University, School of Medicine, New York, NY 10016, United States
    Atherosclerosis 213:586-91. 2010
  2. ncbi Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation
    Jeffrey S Berger
    New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    Thromb Haemost 109:85-92. 2013
  3. ncbi Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature
    Jeffrey S Berger
    New York University Medical Center, New York, NY 10016, USA
    Am Heart J 164:153-162.e5. 2012
  4. ncbi Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass
    Jeffrey S Berger
    New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    J Thromb Thrombolysis 34:56-64. 2012
  5. ncbi Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women
    Jeffrey S Berger
    FAHA, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    Stroke 43:958-66. 2012
  6. ncbi Platelet-directed therapies and coronary artery bypass grafting
    Jeffrey S Berger
    Department of Medicine, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Am J Cardiol 104:44C-8C. 2009
  7. ncbi The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis
    Jeffrey S Berger
    New York University School of Medicine, New York, New York, USA
    J Am Coll Cardiol 54:1935-45. 2009
  8. ncbi Screening for cardiovascular risk in asymptomatic patients
    Jeffrey S Berger
    Department of Medicine, Leon H Charney Division of Cardiovascular Medicine, New York University School of Medicine, New York, New York 10016, USA
    J Am Coll Cardiol 55:1169-77. 2010
  9. ncbi Sex differences in mortality following acute coronary syndromes
    Jeffrey S Berger
    Department of Medicine, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    JAMA 302:874-82. 2009
  10. ncbi Reporting and representation of race/ethnicity in published randomized trials
    Jeffrey S Berger
    New York University School of Medicine, New York, 10016, USA
    Am Heart J 158:742-7. 2009

Detail Information

Publications36

  1. ncbi Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004
    Jeffrey S Berger
    Department of Medicine, Division of Cardiology and Hematology, New York University, School of Medicine, New York, NY 10016, United States
    Atherosclerosis 213:586-91. 2010
    ..We sought to determine whether mean platelet volume (MPV) is associated with the prevalence of peripheral artery disease (PAD)...
  2. ncbi Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation
    Jeffrey S Berger
    New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    Thromb Haemost 109:85-92. 2013
    ....
  3. ncbi Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature
    Jeffrey S Berger
    New York University Medical Center, New York, NY 10016, USA
    Am Heart J 164:153-162.e5. 2012
    ..Current acetylsalicylic acid (ASA) dosing algorithms for the prevention of secondary thrombotic events in acute coronary syndrome (ACS) patients are inconsistent and lack sufficient data support...
  4. ncbi Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass
    Jeffrey S Berger
    New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    J Thromb Thrombolysis 34:56-64. 2012
    ..Clopidogrel treatment within 5 days prior to surgery increased the risk of bleeding and reoperation in all CABG patients irrespective of whether surgery was performed on- or off-pump...
  5. ncbi Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women
    Jeffrey S Berger
    FAHA, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    Stroke 43:958-66. 2012
    ..Few studies simultaneously investigated lipids and lipoprotein biomarkers as predictors of ischemic stroke. The value of these biomarkers as independent predictors of ischemic stroke remains controversial...
  6. ncbi Platelet-directed therapies and coronary artery bypass grafting
    Jeffrey S Berger
    Department of Medicine, New York University School of Medicine, 530 First Avenue, New York, NY 10016, USA
    Am J Cardiol 104:44C-8C. 2009
    ..Whether reversible P2Y(12) receptor antagonists will mitigate the bleeding risk is unclear at the present time and will require large prospective studies...
  7. ncbi The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis
    Jeffrey S Berger
    New York University School of Medicine, New York, New York, USA
    J Am Coll Cardiol 54:1935-45. 2009
    ..This study sought to investigate the efficacy and safety of clopidogrel in women and men...
  8. ncbi Screening for cardiovascular risk in asymptomatic patients
    Jeffrey S Berger
    Department of Medicine, Leon H Charney Division of Cardiovascular Medicine, New York University School of Medicine, New York, New York 10016, USA
    J Am Coll Cardiol 55:1169-77. 2010
    ..Appropriate intervention, guided by risk assessment, has the potential to bring about a significant reduction in population levels of risk...
  9. ncbi Sex differences in mortality following acute coronary syndromes
    Jeffrey S Berger
    Department of Medicine, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA
    JAMA 302:874-82. 2009
    ..Conflicting information exists about whether sex differences modulate short-term mortality following acute coronary syndromes (ACS)...
  10. ncbi Reporting and representation of race/ethnicity in published randomized trials
    Jeffrey S Berger
    New York University School of Medicine, New York, 10016, USA
    Am Heart J 158:742-7. 2009
    ..Although adequate representation of specific subgroups (eg, women and the elderly) in randomized controlled trials (RCTs) has been under intense scrutiny, there are few data on representation by race...
  11. ncbi Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials
    Jeffrey S Berger
    Department of Medicine, Division of Cardiology, New York University School of Medicine, New York, NY 10016, USA
    Am Heart J 162:115-24.e2. 2011
    ..The benefit of aspirin to prevent cardiovascular events in subjects without clinical cardiovascular disease relative to the increased risk of bleeding is uncertain...
  12. ncbi Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis
    Jeffrey S Berger
    Division of Cardiology, Duke University School of Medicine, Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 52:1693-701. 2008
    ..S. hospitals...
  13. ncbi Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
    Jeffrey S Berger
    New York University School of Medicine, New York, NY, USA
    Am Heart J 162:98-105.e1. 2011
    ..We sought to investigate the association between bleeding and mortality subtype, and assess whether this association differs in patients on dual antiplatelet therapy (DAPT) versus aspirin alone...
  14. ncbi The prevalence of carotid artery stenosis varies significantly by race
    Caron B Rockman
    Division of Vascular Surgery, New York University Medical Center, New York, NY 10016, USA
    J Vasc Surg 57:327-37. 2013
    ..The goal of this report was to study the prevalence of CAS in different races by analyzing a population of subjects who underwent vascular screening examinations...
  15. ncbi Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study
    Jeffrey S Berger
    Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Circ Cardiovasc Qual Outcomes 2:78-87. 2009
    ..We sought to evaluate the relationship between aspirin use, dose (81 or 325 mg), and clinical outcomes among postmenopausal women with stable cardiovascular disease (CVD)...
  16. ncbi Impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes and long-term survival following percutaneous coronary rotational atherectomy
    Jeffrey S Berger
    Beth Israel Medical Center, New York, NY, USA
    J Thromb Thrombolysis 19:47-54. 2005
    ..These data do not indicate a significant association between GP IIb/IIIa inhibitor treatment during PCRA and MACE or survival...
  17. ncbi Competency in chest radiography. A comparison of medical students, residents, and fellows
    Lewis A Eisen
    Division of Pulmonary and Critical Care, Beth Israel Medical Center, New York, NY 10010, USA
    J Gen Intern Med 21:460-5. 2006
    ..Accurate interpretation of chest radiographs (CXR) is essential as clinical decisions depend on readings...
  18. ncbi Smoking, clopidogrel, and mortality in patients with established cardiovascular disease
    Jeffrey S Berger
    New York University School of Medicine, New York, NY, USA
    Circulation 120:2337-44. 2009
    ..Smoking increases platelet aggregability and the degree of platelet inhibition by clopidogrel on ex vivo platelet function tests. Whether smoking status affects the relationship between clopidogrel and clinical outcomes is unknown...
  19. ncbi Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials
    Jeffrey S Berger
    Department of Medicine, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, USA
    JAMA 301:1909-19. 2009
    ..Despite guideline recommendations for secondary prevention in peripheral artery disease (PAD), the effect of aspirin in this population is not well established...
  20. ncbi The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004
    Binita Shah
    Department of Medicine, Division of Cardiology, New York University, School of Medicine, New York, New York, USA
    Diabetes Care 35:1074-8. 2012
    ..We aim to investigate mean platelet volume (MPV), a marker of platelet size and platelet activity, with the prevalence of diabetes, metabolic syndrome, and degree of glycemic control...
  21. ncbi Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention
    Jeffrey S Berger
    Department of Medicine (Cardiology, Beth Israel Medical Center, New York, New York 10003, USA
    Am J Cardiol 94:649-51. 2004
    ..001). COPD was independently associated with a 2-fold increase in the hazard of long-term mortality (hazard ratio 2.146, 95% confidence interval 1.525 to 3.021, p < 0.001)...
  22. ncbi Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State
    Jeffrey S Berger
    Division of Cardiovascular Medicine, Department of Medicine, Duke University Medical Center, Durham, NC, USA
    Circ Cardiovasc Interv 2:317-22. 2009
    ..However, there is little data regarding the impact of the presence and extent of vascular disease on outcomes in patients with CAD undergoing percutaneous coronary intervention...
  23. ncbi Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention
    Binita Shah
    Division of Cardiology, Department of Medicine, New York University School of Medicine and Veterans Affairs New York Harbor Health Care System, New York, New York, USA
    Am J Cardiol 111:185-9. 2013
    ..However, increased mortality was found when the MPV increased over time after PCI. Monitoring the MPV after coronary revascularization might play a role in risk stratification...
  24. ncbi Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects
    Nazir Savji
    Department of Medicine, Division of Cardiology, School of Medicine, New York University, New York, New York
    J Am Coll Cardiol 61:1736-43. 2013
    ..This study sought to determine the relationship between vascular disease in different arterial territories and advanced age...
  25. ncbi Competency in electrocardiogram interpretation among internal medicine and emergency medicine residents
    Jeffrey S Berger
    Department of Internal Medicine, Beth Israel Medical Center, New York, New York 10003, USA
    Am J Med 118:873-80. 2005
    ..Our study evaluated the ability of internal medicine residents and emergency medicine residents to interpret a variety of electrocardiograms...
  26. ncbi Outcome of carotid artery interventions among female patients, 2004 to 2005
    Caron B Rockman
    Division of Vascular Surgery, New York University Medical Center, New York, NY, USA
    J Vasc Surg 53:1457-64. 2011
    ..The outcome of carotid angioplasty and stenting (CAS) has not been extensively examined in women. This study examined the outcome of CEA and CAS in women vs men by using a national database...
  27. ncbi Gender disparity in failure rate for arterial catheter attempts
    Lewis A Eisen
    Division of Pulmonary and Critical Care Medicine, Beth Israel Medical Center, New York, NY 10003, USA
    J Intensive Care Med 22:166-72. 2007
    ..The strongest predictor of failure was female gender. A possible explanation not explored here could be smaller arterial size in female patients...
  28. ncbi Mechanical complications of central venous catheters
    Lewis A Eisen
    Beth Israel Medical Center, Pulmonary Division, 7 Dazian, 17th Street at 1st Avenue, NY, NY 10010, USA
    J Intensive Care Med 21:40-6. 2006
    ..24%, P = .02). The complication rate increased with the number of percutaneous punctures, with a rate of 54% when more than 2 punctures were required...
  29. ncbi Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data
    Gaurav Sharma
    Division of Cardiology, Department of Medicine, New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY 10016, USA
    J Thromb Thrombolysis 32:201-8. 2011
    ....
  30. ncbi G-protein-coupled receptors as signaling targets for antiplatelet therapy
    Susan S Smyth
    Veterans Affairs Medical Center, Department of Medicine, Physiology, and Pharmacology, University of Kentucky, Lexington, KY, USA
    Arterioscler Thromb Vasc Biol 29:449-57. 2009
    ..The identification and development of new agents directed against specific platelet signaling pathways may offer an advantage in preventing thrombotic events while minimizing bleeding risk...
  31. ncbi Peripheral artery disease, biomarkers, and darapladib
    Jeffrey S Berger
    New York University School of Medicine, NY, USA
    Am Heart J 161:972-8. 2011
    ..We therefore sought to investigate the relationship between PAD and levels of inflammatory, platelet, and lipid biomarkers and the treatment effect of darapladib, a novel lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) inhibitor...
  32. ncbi Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials
    Richard Andraws
    Cardiovascular Medicine, Department of Medicine, Beth Israel Medical Center, New York, NY, USA
    JAMA 293:2641-7. 2005
    ..2% vs 9.6%; OR, 0.91; 95% CI, 0.76-1.07; P = .25). CONCLUSION: Evidence available to date does not demonstrate an overall benefit of antibiotic therapy in reducing mortality or cardiovascular events in patients with CAD...
  33. ncbi Thrombotic and bleeding complications after orthopedic surgery
    Brandon S Oberweis
    Department of Medicine, New York University Langone Medical Center, New York, NY, USA
    Am Heart J 165:427-33.e1. 2013
    ....
  34. ncbi A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes
    Jeffrey S Berger
    Division of Cardiology, Duke University School of Medicine and Duke Clinical Research Institute, Durham, NC 27715, USA
    Platelets 20:302-15. 2009
    ..Investigation of practical ex vivo platelet performance measurement tools is actively proceeding and may provide important information for patient management...
  35. ncbi Comparison of three-year outcomes in blacks versus whites with coronary heart disease following percutaneous coronary intervention
    Jeffrey S Berger
    Department of Medicine (Cardiology, Beth Israel Medical Center, New York, New York 10003, USA
    Am J Cardiol 94:647-9. 2004
    ..The investigators analyzed the impact of race on 3-year survival in 3,783 consecutive patients who underwent PCI in 1998 and 1999...
  36. ncbi Impact of gender on mortality following primary angioplasty for acute myocardial infarction
    Jeffrey S Berger
    Department of Medicine (Cardiology, Beth Israel Medical Center, New York, NY 10003, USA
    Prog Cardiovasc Dis 46:297-304. 2004